Triple-negative breast cancer (TNBC) presents an aggressive subtype of breast cancer with inferior survival outcomes, as it lacks molecular biomarkers such as estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) [1]. Here, ERBB2 is linked to breast cancer.